nimodipine has been researched along with Infant, Newborn, Diseases in 2 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
McGowan, B | 1 |
Khaira, G | 1 |
Coghlan, MA | 1 |
Shaibani, A | 1 |
Alden, TD | 1 |
Pardo, AC | 1 |
Pei, LN | 1 |
Liu, XH | 1 |
Zhang, H | 1 |
Zhu, J | 1 |
Gao, Z | 1 |
Bi, MZ | 1 |
2 other studies available for nimodipine and Infant, Newborn, Diseases
Article | Year |
---|---|
Use of Nimodipine in a Neonate With Cerebral Vasospasm With Delayed Ischemia From Subarachnoid Hemorrhage in the Posterior Fossa.
Topics: Angiography, Digital Subtraction; Brain Ischemia; Cerebral Angiography; Cranial Fossa, Posterior; Hu | 2020 |
Clinical efficacy of mouse nerve growth factor plus nimodipine in neonatal intracranial hemorrhage and its effect on plasma PAF, CNP, MMP-2, and neurological function.
Topics: Animals; Humans; Infant, Newborn; Infant, Newborn, Diseases; Injections, Intramuscular; Intracranial | 2021 |